SOPHiA GENETICS SA (SOPH): A Bull Case Theory

We came across a bullish thesis on SOPHiA GENETICS SA (SOPH) on Two Natural Cap’s Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SOPH. SOPHiA GENETICS SA (SOPH)'s share was trading at $3.64 as of Nov 1^st.

[caption id="attachment_1228454" align="aligncenter" width="768"] A clinical medical professional helping a patient while using an integrated health information technology software.[/caption]

Sophia Genetics is carving out a unique niche in the crowded cancer screening market, distinguishing itself from competitors like Grail,...